A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2006
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006115067A1 Peritoneal dialysis fluid
11/02/2006	WO2006115057A1 Artificial cerebrospinal fluid
11/02/2006	WO2006114691A1 Erythrocytes containing arginine deiminase
11/02/2006	WO2006114415A2 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester
11/02/2006	WO2006093823A9 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247298 {[((1E)-{4-[3-(4-tert-butylphenoxy)prop-1-ynyl]phenyl}methylidene)amino]oxy}acetic acid; plasminogen activator inhibitor, anticoagulant; venous, arterial, cerebral, and deep vein thrombosis, atrial fibrillation, pulmonary fibrosis, myocardial ischemia, atherosclerotic plaque formation
11/02/2006	US20060247273 Carbamoyl-type benzofuran derivatives
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247179 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/02/2006	US20060246547 Nematode-extracted serine protease inhibitors and anticoagulant proteins
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246053 Frozen and lyophilized compositions for a metalloproteinase fibrinolytic agent (fibrolase or "novel acting thrombolytic agent" (NAT) with buffer of sodium citrate, zinc acetate, and/or calcium acetate; regeneration
11/02/2006	US20060246046 Modified tridegins, production and use thereof as transglutaminase inihibitors
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1501565B1 Compounds and method for coating surfaces in a haemocompatible manner
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006	EP1244446B1 Thrombopoietin mimetics
11/02/2006	EP1036063B1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
11/02/2006	EP1009417B1 Dietary supplements containing natural ingredients
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0950416B1 Use of TCF-II for the treatment of cancer related body weight loss, anaemia and TNF elevation
11/02/2006	DE102005020002A1 New hexyloxycarbonylamino-imino-methyl-phenylamino-methyl-benzimidazo le-pyridine-propionic acid-ethyl ester salts such as hydrochloride useful for the prophylaxis of vein thrombosis and stroke
11/02/2006	CA2609656A1 Compositions and methods for promoting hemostasis and other physiological activities
11/02/2006	CA2608111A1 Production of emulsions for intravenous injection of water-insoluble pharmaceutical compositions
11/02/2006	CA2606420A1 Erythrocytes containing arginine deiminase
11/02/2006	CA2606343A1 A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
11/02/2006	CA2606090A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605480A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls
11/02/2006	CA2604603A1 Novel cyclic amines
11/02/2006	CA2604454A1 Artificial cerebrospinal fluid
11/01/2006	CN1856504A Anti-infarction molecules
11/01/2006	CN1856488A Carbamoyl-type benzofuran derivatives
11/01/2006	CN1853729A Preparation of polynuclear iron hydroxide-sugar composite
11/01/2006	CN1853728A Method prescription and use for improving medicine or nutrient oral absorption
11/01/2006	CN1853707A Yixuening oral liquid
11/01/2006	CN1853706A Apoplectic Naoluofang
11/01/2006	CN1853679A Medicinal composition for treating cervical spondylosis and preparation thereof
11/01/2006	CN1853674A Quality controlling method of Xingdan injection
11/01/2006	CN1853671A Thrombolytic collaterals-activating preparation for treating angiitis and phlebitis and making method thereof
11/01/2006	CN1853668A Chinese medicinal composition for strengthening body and enriching blood
11/01/2006	CN1853660A Erigeron breviscapus preparation and making method thereof
11/01/2006	CN1853646A Compound three-vitamines B injection and preparation thereof
11/01/2006	CN1282645C Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
11/01/2006	CN1282472C Anthemonhagic medicament for quick blood coagulation and diminish inflammation
11/01/2006	CN1282469C Chinese medicine for preventing hemolysis, preventing miscarriage and tonifying brain to prevent blood group incompatibility hemolysis disease in pregnancy
11/01/2006	CN1282452C Use of aminoadamantane compound as immunoregulators
10/2006
10/31/2006	US7129270 Antiinflammatory agents
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129255 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/31/2006	US7129253 Compounds
10/31/2006	US7129245 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7128913 Erythropoietin conjugates
10/31/2006	CA2172350C Preparation of autologous plasma and fibrin gel
10/31/2006	CA2142811C Novel glucan preparation
10/26/2006	WO2006111085A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients
10/26/2006	WO2006084210A9 Hif modulating compounds and methods of use thereof
10/26/2006	WO2006078621B1 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
10/26/2006	US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof
10/26/2006	US20060241181 Alpha-ketoglutarates of active ingredients and compositions containing same
10/26/2006	US20060241153 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
10/26/2006	US20060241116 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
10/26/2006	US20060241111 inhibitors of coagulation factor Xa such as 1-(5-chlorothien-2-ylcarbonyl)-4-[4-(3-oxomorpholin-4-yl)phenyl]-2-propylsemicarbazide, used for preventing thrombosis, infarction, arteriosclerosis, inflammation, bleeding, angina pectoris, restenosis, intermittent claudication and treatment of tumors
10/26/2006	US20060241051 Metastin derivatives and use thereof
10/26/2006	US20060240525 Factor VII or VIIa - Like Molecules
10/26/2006	US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
10/26/2006	US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity
10/26/2006	US20060240519 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
10/26/2006	US20060240517 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240476 Thrombotic thrombocytopenic purpura (TTP); epitope recognized by an antibody (anti-ADAMTS-13 antibody) against a cleaving protease ( ADAMTS-13) specific to von Willebrand factor
10/26/2006	US20060240114 Drug for treating hemophilia and method of treating hemophilia using the same
10/26/2006	US20060240113 Anticancer agents; prevent forming blood vessels; removal blockager
10/26/2006	US20060240023 Apoptosis-associated protein and use thereof
10/26/2006	US20060239912 Carrier molecules
10/26/2006	DE102005018690A1 Imino-oxazolidine und ihre Verwendung Imino-oxazolidines and their use
10/26/2006	CA2605492A1 Iminooxazolidines and their use
10/25/2006	EP1715034A1 Regulatory cell controlling immunological activity of t cell
10/25/2006	EP1714661A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
10/25/2006	EP1714657A1 Solid formulation for dialysis and process for producing the same
10/25/2006	EP1713774A1 New pyridin-2-one compounds useful as inhibitors of thrombin
10/25/2006	EP1509498B1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
10/25/2006	EP1509231A4 Peritoneal dialysis solution with taurolidine
10/25/2006	EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006	EP1430053B1 AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN
10/25/2006	EP1187613B9 Amide substituted imidazoquinolines
10/25/2006	CN1852926A Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
10/25/2006	CN1852890A Abiotic heparin antagonists
10/25/2006	CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
10/25/2006	CN1852710A Pyrazolines as PAR-1 antagonists for treatment of cardiovascular diseases
10/25/2006	CN1852709A Macrophage activation inhibitor
10/25/2006	CN1850976A Glucose kinase derivant for inhibiting platelet aggregation and thrombase activity, and its preparing method
10/25/2006	CN1850764A 6,7-dehydroxyleanone in salvia farinacea root with platelet aggregation inhibition

1 ... 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 ... 671